Percutaneous Electrical Nerve Stimulation for Chronic Knee Pain: A Randomized, Sham-controlled Trial

Zheng-fa Bai, MM; Da-peng He, MB; Jun Zhang, MB

Context • Anti-inflammatory drugs are often used to treat chronic knee pain (CKP), but their long-term use is associated with decreased effectiveness and numerous side effects. Complementary and alternative medicine provides additional treatments for the condition, including percutaneous electrical nerve stimulation (PENS). However, the benefits of PENS for treatment of CKP are still controversial. Objective • The study intended to assess the effects and safety of PENS for treatment of CKP. Methods • This study was a 2-arm, randomized, sham-controlled trial. Setting: The study took place at the Fourth People’s Hospital of Shaanxi (Xi’an, China). Participants • Participants were 72 patients at the hospital being treated for CKP. Intervention • Participants were randomly divided into a real PENS group and a sham PENS group at a ratio of 1:1. All patients received etoricoxib and either real or sham PENS therapy, 3 ×/wk for 8 wk, at the same local acupoints around the knee. Outcome Measures • The primary outcome, pain, was measured on a numeric rating scale (NRS). Secondary outcomes, stiffness and physical function, were evaluated using the Western Ontario and McMaster Universities arthritis index (WOMAC) and the short-form 36-item health survey (SF-36) to obtain a score on the physical component scale (PCS) and the mental component scale (MCS). The NRS and the WOMAC were administered at initiation of treatment to establish a baseline and again after 8 wk of treatment. The SF-36 was administered postintervention. Results • At the end of 8 wk, the group receiving the real PENS exhibited statistically significant improvements in both primary and secondary outcomes compared with the group receiving the sham PENS treatment. Conclusions • The findings suggest that treatment with the real PENS with etoricoxib is effective for treatment of CKP.

I am a subscriber to ATHM and would like to read this article
I would like to purchase this article - $35.00
I would like to subscribe to ATHM for $55.00 and obtain access to this article